Retinal Vein Occlusion With Macular Edema Clinical Trial
Official title:
Comparison of Therapeutic Effects Between Intravitreal Injection of Bevacizumab With Intravitreal Injection of Bevacizumab and Targeted Laser Photocoagulation of Non Perfused Areas of Retina in Patients With Acute Retinal Vein Occlusion
Patients with new onset retinal vein occlusion in less than 3 month whom has visual acuity
less than 20/40 and central macular thickness more than 250micrometer and non perfused areas
of retina more than 10 DD are included in over study and devided into 2 groups randomizely,
Group A under gone 3 intravitreal injection of bevacizumab monthly and examine monthly for
Visual acuity and central macular thickness, if in month four or more the CMT is more than
250 micrometer and the visual acuity is less than 8/10 the injection is repeated and follow
up in this manner is continued until 9 months.
Group B is as the same of group A but patients in this group undergone laser photocoagulation
of retinal non perfused areas based on FAG wide field imaging .
After 9 month follow up the outcomes such as Vusal acuity, Central macular thickness,
intraocular pressure, neovascular formation are compared,
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04455399 -
Time Efficiency Comparison of Two IntraVitreal Injection Techniques
|
N/A |